1.The gene amplification rate was higher in lung squamous cell carcinoma patients;
2.There was a significant difference in EGFR mutation rate between those without amplification and those without amplification.
3.The prognosis is worse.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.